Let’s dig into the relative performance of Cigna (NYSE:CI) and its peers as we unravel the now-completed Q4 health insurance ...

Cigna Group (NYSE:CI) has seen its share price increase by 11% over the last quarter amid various significant events within the company. Recently announced executive changes include Brian Evanko being ...

Cigna looks undervalued at under 10x earnings, with strong growth potential. Evernorth continues to expand, adding to the company’s long-term value. Large stock buybacks are supporting earnings ...

Cigna delivered a strong Q4 performance, with revenue surging 28.4% year over year to $65.65 billion. This exceeded analyst ...

US managed care insurers' Q4 2024 earnings season was characterized by generally higher medical costs amid ongoing changes to federally subsidized healthcare plans.

Cigna's fourth-quarter results were impacted ... which measures medical costs as a percentage of premiums, rose to 87.9% in Q4 from 82.2% a year earlier. "While higher medical costs in our stop ...

Wrapping up Q4 earnings, we look at the numbers and key takeaways for ... Serving both corporate clients and individual ...

Health insurance company Cigna (NYSE:CI) announced better-than-expected revenue in Q4 CY2024, with sales up 28.4% year on year to $65.65 billion. The company expects the full year’s revenue to be ...

Revenue (Q4 2024): $298.4 million, up 11% year-over-year ... Progyny Inc (NASDAQ:PGNY) retained 99% of its clients and expanded its partner network, including adding Cigna as its first national health ...

Cigna reported fourth-quarter 2024 adjusted earnings per share of $6.64, which missed the Zacks Consensus Estimate by 15.2% due to a decline in its overall medical customer base and elevated ...

Newron Pharmaceuticals S.p.A. ("Newron") (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for diseases of the central and peripheral nervous system, ...

Twist Bioscience Corporation , a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced that, for a limited time, all Twist Express Genes ...